Immediate Impact

5 by Nobel laureates 14 from Science/Nature 64 standout
Sub-graph 1 of 23

Citing Papers

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Standout
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
2022 Standout
2 intermediate papers

Works of Phillip Oliver being referenced

Omeprazole in the treatment of asthmatics with nocturnal symptoms and gastro-oesophageal reflux: a placebo-controlled cross-over study
1994
An Eudragit‐coated prednisolone preparation for ulcerative colitis: pharmacokinetics and preliminary therapeutic use
1992

Author Peers

Author Last Decade Papers Cites
Phillip Oliver 209 73 188 95 46 567
Anna Stolarczyk 251 28 181 43 31 535
Michael H. Hart 138 47 43 64 33 558
So Youn Park 86 91 139 85 49 630
Wei Tan 77 38 77 63 39 634
Richard Sloane 196 59 121 166 20 627
Stephen R. Holt 194 13 198 104 43 571
Clyve Yu Leon Yaow 40 97 114 43 36 585
James A. Kashanian 90 48 101 89 27 577
Manuel Moya Benavent 140 26 133 66 66 526
Peter Baume 268 22 27 172 63 639

All Works

Loading papers...

Rankless by CCL
2026